Nearly 3,000 Swedish Medical Center patients at risk for HIV, hepatitis

Englewood, Colo.-based Swedish Medical Center is notifying patients who had surgery at the facility between Aug. 17, 2015, and Jan. 22 they may be at risk for HIV and hepatitis B and C, according to the Denver Post.

Advertisement

The hospital issued the warning after discovering a former Swedish employee, a surgical technician, was diverting drugs and possibly leaving behind dirty needles. The hospital subsequently removed him from patient care, his surgical technician’s license was suspended and he is being investigated by the Englewood Police Department.

Swedish is offering free, confidential blood tests to all surgical patients who underwent care at locations where the employee worked — the number of potentially affected patients totals roughly 2,900. Currently, there is no known transmission to patients, according to the Post.

More articles on patient safety:
Legionnaires’ disease can spread person-to-person, study suggests
Flu vaccination rates among US babies remains low, study finds
Longer surgical resident hours don’t hinder patient care, study says

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

When nurses help build the AI, adoption follows: Lessons from 3 health systems

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Amy McCarthy, DNP, RNC-MNN, NE-BC, CENP, Hippocratic AIBeth Reimschissel, PhD, RN, CNL, Memorial HermannAllison Schlinkert, MSN, RN, NPD-BC, Cincinnati Children'sScott Estep, MBOE, BSN, RN, CSSBB, OhioHealth System

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.